학술논문
738P - Strong tumour cytidine deaminase (CDA) staining predicts for improved survival associated with sequential nab-Paclitaxel (nabP) and gemcitabine (GEM) chemotherapy as first line treatment of patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2017 28 Supplement 5:v251-v252
Subject
Language
ISSN
0923-7534